Form 8-K Eton Pharmaceuticals, For: Apr 15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Fox Factory sells Marucci Sports for $225M, cuts debt
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
Eton Pharmaceuticals Inc. (ETON) Enters Share and Warrant Sale Agreements
April 18, 2024 4:26 PM EDT(Updated - April 18, 2024 4:27 PM EDT)
On April 15, 2024, Eton Pharmaceuticals Inc. (NASDAQ: ETON) entered into (i) agreements to issue and sell 1,287,500 shares of common stock at a price of $3.50 per share or total proceeds of $4,506,250, (ii) agreements to issue pre-funded warrants to purchase... More
